Cytek Biosciences shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Cytek Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Cytek Biosciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytek Biosciences by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 359k | 3.47 |
| 2025-03-31 | $2.7M | 671k | 4.01 |
| 2024-12-31 | $6.1M | 948k | 6.49 |
| 2024-09-30 | $3.3M | 599k | 5.54 |
| 2024-06-30 | $3.4M | 608k | 5.58 |
| 2024-03-31 | $573k | 85k | 6.71 |
| 2023-12-31 | $1.3M | 148k | 9.12 |
| 2023-09-30 | $763k | 138k | 5.52 |
| 2023-06-30 | $1.2M | 145k | 8.54 |
| 2023-03-31 | $17M | 2.2k | 7740.38 |
| 2022-12-31 | $697k | 68k | 10.21 |
| 2022-06-30 | $615k | 62k | 10.00 |
| 2022-03-31 | $538k | 50k | 10.77 |
| 2021-12-31 | $162k | 9.9k | 16.31 |